The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations (Q46789897)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2005

edit

Language	Label	Description	Also known as
English	The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations	scientific article published in November 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

title

The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

main subject

ritonavir

1 reference

based on heuristic

inferred from title

author name string

Shafran SD

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

Mashinter LD

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

Roberts SE

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

publication date

1 November 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

published in

HIV Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

volume

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

page(s)

421-425

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

cites work

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

HIV-protease inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Sex differences in HAART-associated dyslipidaemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00328.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1468-1293.2005.00328.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

PubMed publication ID

16268824

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16268824

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16268824

ResearchGate publication ID

7498948

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46789897&oldid=2217071235"